Wellgistics Health, Inc. (WGRX)
| Market Cap | 10.58M -95.2% |
| Revenue (ttm) | 23.34M +28.7% |
| Net Income | -101.27M |
| EPS | -1.43 |
| Shares Out | 125.67M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 3,100,150 |
| Open | 0.0891 |
| Previous Close | 0.0883 |
| Day's Range | 0.0831 - 0.0941 |
| 52-Week Range | 0.0794 - 7.0400 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | May 21, 2026 |
About WGRX
Wellgistics Health, Inc. engages in the wholesale and distribution of pharmaceutical products to pharmaceutical manufacturers and independent retail pharmacies in the United States. The company distributes branded and generic pharmaceuticals, as well as over-the-counter healthcare and consumer products. It also offers third-party logistics services that include warehousing, inventory management, pick and pack, and shipping to small and mid-size pharmaceutical manufacturers. It also operates DelivMeds platform that serves as a pharmaceutical hub... [Read more]
Financial Performance
In 2025, Wellgistics Health's revenue was $23.34 million, an increase of 28.73% compared to the previous year's $18.13 million. Losses were -$101.27 million, 1377.1% more than in 2024.
Financial StatementsNews
Wellgistics Health files $200M mixed securities shelf
17:25 EDT Wellgistics Health (WGRX) files $200M mixed securities shelf
Wellgistics Health, Kare PharmTech execute joint venture
Wellgistics Health (WGRX) announced the execution of a definitive joint venture agreement with Kare PharmTech’s wholly owned subsidiary, Kare Rx Hub, an artificial intelligence-driven digital hub supp...
Wellgistics Health and Kare PharmTech Execute Joint Venture Expanding Access to 200,000+ Patient Lives
Joint venture executed combining Wellgistics Hub and KareRx Hub technology and operations Integrated platform accelerates pharmaceutical access, fulfillment, and commercialization Combined ecosystem p...
Wellgistics enters LOI to evaluate potential acquisition of Neuritek
Wellgistics Health (WGRX) announced that it has entered into a non-exclusive, non-binding Letter of Intent, LOI, to evaluate a potential acquisition of Neuritek Therapeutics, a neuroscience-focused re...
Wellgistics Health Inc. Signs $105,000,000 Letter of Intent to Evaluate Potential Acquisition of Neuritek Therapeutics, Inc. which is Pioneering Innovative Therapies for Neurological and Psychiatric Disorders
TAMPA, FL / ACCESS Newswire / March 23, 2026 / Wellgistics Health, Inc. ("Wellgistics" or the "Company") (NASDAQ:WGRX) today announced that it has entered into a non-exclusive, non-binding Letter of I...
Wellgistics Health converts $2M in deferred compensation equity at 20c per share
Wellgistics Health (WGRX), announced that its President and Interim Chief Executive Officer, Prashant Patel, together with an additional participant from the Company’s Board of Directors, entered into...
Wellgistics Management Converts $2 Million in Deferred Compensation into Equity at $0.20 per Share
TAMPA, FL / ACCESS Newswire / March 19, 2026 / Wellgistics Health, Inc. (NASDAQ:WGRX) ("Wellgistics"), a health information technology leader, integrating proprietary pharmacy dispensing optimization ...
Wellgistics President Releases Letter to Shareholder on Emerging Patient Care-Centric Strategic Direction
TAMPA, FL / ACCESS Newswire / March 13, 2026 / Wellgistics Health, Inc. (NASDAQ:WGRX) ("Wellgistics"), a health information technology leader, integrating proprietary pharmacy dispensing optimization ...
Wellgistics Health announces insurance EBV capabilities for PharmacyChain
Wellgistics Health (WGRX) has secured contractual rights to preferred pricing for medical insurance eligibility and benefits verification that enables PharmacyChain for providers, partners and pharmac...
Wellgistics Strengthens PharmacyChain(TM) with Insurance Eligibility & Benefits Verification Capabilities
Medical insurance eligibility and benefits verification (EBV) is a core health technology capability necessary for PharmacyChain™ to gain market adoption EBV services offering enabled with preferred p...
Wellgistics Health launches Forzet for muscle loss linked with weight loss drugs
Wellgistics Health (WGRX) announced the launch of medical food Forzet for the dietary management of muscle loss associated with weight loss therapies. Forzet is being launched initially to physicians ...
Wellgistics Targets $70B Market Breakthrough Addressing Ozempic / GLP-1 Muscle Loss with Forzet(TM)
GLP-1 agonist market expected to grow from $70B in 2025 to $201B in 20301 Proprietary Forzet formulation provides pharmacists, physicians and patients with unique solution for GLP-1 drugs' primary sid...
Wellgistics selects five blockchain platforms for PharmacyChain development
Wellgistics Health (WGRX) has completed its evaluation process to select the most suitable blockchain platforms on which to build smart contracts-enabled pharmaceutical drug tracking system PharmacyCh...
Wellgistics Health Selects Top Five Blockchain Platforms to Initiate Patent Protected PharmacyChain(TM) Smart Contracts-enabled Pharmaceutical Drug Tracking System to Support Industry-wide Serialization Mandate
Hyperledger Fabric, Ethereum/Polygon, VeChain, Quorum /Besu and Corda (R3) selected as most suitable blockchain platforms to build PharmacyChain™ U.S. prescription drugs market project to grow from $6...
Datavault, Wellgistics Health announce plans to expand partnership
Datavault AI (DVLT) and Wellgistics Health (WGRX) announced plans to expand their existing blockchain-enabled smart contracts partnership initially focused on digitizing tracking of prescription drugs...
Wellgistics Health completes investment in mental health AI startup
Wellgistics Health (WGRX) announced that it has completed a strategic investment in a San Francisco-based mental health AI startup on the cusp of launching its service following beta testing. The
Wellgistics Health Targets Expansion into $6.3 Billion Mental Health Software Market with Strategic Investment into Stealth Mental Health AI Startup
Previously announced partnership with Tollo Health subsidiary TolloCare adding telehealth service offering to drive Wellgistics Pharmacy prescription drug dispending of GLP-1 drugs and promote patient...
Wellgistics Health to Add Telehealth & Mental Health AI Capabilities via Tollo Health Partnership Expansion
Tollo Health recently formed subsidiary TolloCare, LLC ('TolloCare') initially targeted to provide telehealth services for GLP-1 and Long COVID patients TolloCare has white-labeled telehealth capabili...
Wellgistics Health partners with NFL Alumni Health
Wellgistics Health (WGRX) entered into an agreement with NFL Alumni Health to establish healthcare and wellness programs that expand access to healthcare and wellness services, improve cost transparen...
Wellgistics Health provides update on Datavault partnership
Wellgistics Health (WGRX) provided an update on its strategic licensing partnership with DataVault AI (DVLT). Through this partnership, Wellgistics has licensed DataVault AI’s advanced technology plat...
Wellgistics Health Adds Quantum Key Encryption to PharmacyChain(TM) AI-Enabled Blockchain Smart Contract Partnership with DataVault AI
Feasibility assessment completed, PharmacyChain™ to leverage Datavault AI's edge network and quantum key encryption to improve data driven outcomes in $634 billion prescription drug market Quantum key...
Wellgistics Health provides corporate outlook for 2026
Wellgistics Health (WGRX) provided a corporate outlook for 2026 to stakeholders. “Three months following my return to the role of President at Wellgistics, the Company now has a clear direction
Wellgistics Health Provides 2026 Corporate Outlook
Integration of prescription drug dispensing optimization aritifical intelligence platform EinsteinRx™ into pharmacy client point-of-sales systems has commenced EinsteinRx integration streamlining effo...
Wellgistics reminds shareholders of record date for Dream Bowl 2026 tokens
Wellgistics Health (WGRX) reminded shareholders of the December 19, 2025 record date to receive Dream Bowl 2026 Meme Coin tokens. All eligible record holders of Wellgistics Health common stock will
Wellgistics Health Reminds Shareholders of December 19, 2025 Record Date for Dream Bowl 2026 Meme Coin Tokens
TAMPA, FL / ACCESS Newswire / December 17, 2025 / Wellgistics Health, Inc. ("Wellgistics") (NASDAQ:WGRX), a health information technology leader, integrating proprietary pharmacy dispensing optimizati...